Paul W. Shabram
Chief Tech/Sci/R&D Officer chez BIORA THERAPEUTICS, INC.
Profil
Paul W.
Shabram is the founder of Ventana Biosciences, Inc. He is currently the Senior Vice President-Technical Operations at Biora Therapeutics, Inc. He previously worked as Vice President-Operations at Emergent Travel Health, Inc. and Vice President-Technical Development at Emergent BioSolutions, Inc. Shabram completed his undergraduate degree at the University of California, Santa Cruz and earned an MBA from the University of Phoenix.
Postes actifs de Paul W. Shabram
| Sociétés | Poste | Début |
|---|---|---|
| BIORA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 25/04/2022 |
Anciens postes connus de Paul W. Shabram
| Sociétés | Poste | Fin |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Chief Tech/Sci/R&D Officer | - |
| Ventana Biosciences, Inc. | Founder | - |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Formation de Paul W. Shabram
| University of California, Santa Cruz | Undergraduate Degree |
| University of Phoenix | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| BIORA THERAPEUTICS, INC. | Health Services |
| Entreprise privées | 2 |
|---|---|
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technology Services |
| Ventana Biosciences, Inc. |
